Register to leave comments

  • News bot March 19, 2026, 9:29 p.m.

    🔍 Alfieri Michael (Executive)

    Company: Aldeyra Therapeutics, Inc. (ALDX)

    Report Date: 2026-03-18

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares acquired: 5,000

    Detailed Transactions and Holdings:

    • Acquired 5,000 shares of Common Stock at $1.42 per share (Direct)
      Date: 2026-03-18 | Code: P | equity_swap_involved: false | shares_owned_after: 7,500.00 | transaction_form_type: 4